91959205/National Natural Science Foundation of China[Grants and Funding] - Search Results

Year	Number of Results
2021	1
2022	2
2023	3
2024	7

1

Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study.

Peng Z, Liu T, Wei J, Wang A, He Y, Yang L, Zhang X, Fan N, Luo S, Li Z, Gu K, Lu J, Xu J, Fan Q, Xu R, Zhang L, Li E, Sun Y, Yu G, Bai C, Liu Y, Zeng J, Ying J, Liang X, Xu N, Gao C, Shu Y, Ma D, Dai G, Li S, Deng T, Cui Y, Fang J, Ba Y, Shen L. Peng Z, et al. Cancer Commun (Lond). 2021 Nov;41(11):1173-1182. doi: 10.1002/cac2.12214. Epub 2021 Oct 19. Cancer Commun (Lond). 2021. PMID: 34665942 Free PMC article. Clinical Trial.

2

Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data.

Chen Z, Chen Y, Sun Y, Tang L, Zhang L, Hu Y, He M, Li Z, Cheng S, Yuan J, Wang Z, Wang Y, Zhao J, Gong J, Zhao L, Cao B, Li G, Zhang X, Dong B, Shen L. Chen Z, et al. Signal Transduct Target Ther. 2024 Aug 26;9(1):222. doi: 10.1038/s41392-024-01932-y. Signal Transduct Target Ther. 2024. PMID: 39183247 Free PMC article.

3

ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts.

Jiang F, Jia K, Chen Y, Ji C, Chong X, Li Z, Zhao F, Bai Y, Ge S, Gao J, Zhang X, Li J, Shen L, Zhang C. Jiang F, et al. Adv Sci (Weinh). 2023 Aug;10(24):e2300881. doi: 10.1002/advs.202300881. Epub 2023 Jun 21. Adv Sci (Weinh). 2023. PMID: 37341301 Free PMC article.

4

Analyzing the associations between tertiary lymphoid structures and postoperative prognosis, along with immunotherapy response in gastric cancer: findings from pooled cohort studies.

Peng H, Wu X, Zhang C, Liang Y, Cheng S, Zhang H, Shen L, Chen Y. Peng H, et al. J Cancer Res Clin Oncol. 2024 Mar 22;150(3):153. doi: 10.1007/s00432-024-05672-y. J Cancer Res Clin Oncol. 2024. PMID: 38519621 Free PMC article.

5

The tumor immune microenvironment remodeling and response to HER2-targeted therapy in HER2-positive advanced gastric cancer.

Jiang L, Zhao X, Li Y, Hu Y, Sun Y, Liu S, Zhang Z, Li Y, Feng X, Yuan J, Li J, Zhang X, Chen Y, Shen L. Jiang L, et al. IUBMB Life. 2024 Jul;76(7):420-436. doi: 10.1002/iub.2804. Epub 2023 Dec 21. IUBMB Life. 2024. PMID: 38126920

6

Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis.

Li Y, Jiang L, Chen Y, Li Y, Yuan J, Lu J, Zhang Z, Liu S, Feng X, Xiong J, Jiang Y, Zhang X, Li J, Shen L. Li Y, et al. Gastric Cancer. 2024 May;27(3):519-538. doi: 10.1007/s10120-024-01486-6. Epub 2024 Mar 9. Gastric Cancer. 2024. PMID: 38460015 Free PMC article.

7

Deep learning model based on multi-lesion and time series CT images for predicting the benefits from anti-HER2 targeted therapy in stage IV gastric cancer.

He M, Chen ZF, Liu S, Chen Y, Zhang H, Zhang L, Zhao J, Yang J, Zhang XT, Shen L, Gao JB, Dong B, Tang L. He M, et al. Insights Imaging. 2024 Feb 27;15(1):59. doi: 10.1186/s13244-024-01639-2. Insights Imaging. 2024. PMID: 38411839 Free PMC article.

8

The Association between Blood Indexes and Immune Cell Concentrations in the Primary Tumor Microenvironment Predicting Survival of Immunotherapy in Gastric Cancer.

Yuan J, Zhao X, Li Y, Yao Q, Jiang L, Feng X, Shen L, Li Y, Chen Y. Yuan J, et al. Cancers (Basel). 2022 Jul 25;14(15):3608. doi: 10.3390/cancers14153608. Cancers (Basel). 2022. PMID: 35892867 Free PMC article.

9

Deep learning-based radiomics model can predict extranodal soft tissue metastasis in gastric cancer.

Liu S, Deng J, Dong D, Fang M, Ye Z, Hu Y, Li H, Zhong L, Cao R, Zhao X, Shang W, Li G, Liang H, Tian J. Liu S, et al. Med Phys. 2024 Jan;51(1):267-277. doi: 10.1002/mp.16647. Epub 2023 Aug 13. Med Phys. 2024. PMID: 37573524

10

Phase I study of BC001, a novel fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2, in advanced solid tumors.

Liu D, Gong J, Liu M, Zhou H, Wang S, Yang J, Shang C, Guo X, Wang C, Zhang Y, Shen L. Liu D, et al. Cancer Med. 2024 Nov;13(22):e70208. doi: 10.1002/cam4.70208. Cancer Med. 2024. PMID: 39562838 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year